96 related articles for article (PubMed ID: 15888669)
1. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration.
Kamat CD; Green DE; Curilla S; Warnke L; Hamilton JW; Sturup S; Clark C; Ihnat MA
Toxicol Sci; 2005 Aug; 86(2):248-57. PubMed ID: 15888669
[TBL] [Abstract][Full Text] [Related]
2. Arsenic stimulates angiogenesis and tumorigenesis in vivo.
Soucy NV; Ihnat MA; Kamat CD; Hess L; Post MJ; Klei LR; Clark C; Barchowsky A
Toxicol Sci; 2003 Dec; 76(2):271-9. PubMed ID: 12970581
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells.
Soucy NV; Klei LR; Mayka DD; Barchowsky A
Chem Res Toxicol; 2004 Apr; 17(4):555-63. PubMed ID: 15089098
[TBL] [Abstract][Full Text] [Related]
4. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
8. [Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].
Han YL; He DL; Luo Y; Cheng HP; Zhu GF
Zhonghua Nan Ke Xue; 2008 May; 14(5):439-44. PubMed ID: 18572865
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
Fang J; Yan L; Shing Y; Moses MA
Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
11. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
12. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
13. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
14. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.
Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS
Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432
[TBL] [Abstract][Full Text] [Related]
15. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha promotes tumor growth by inducing vascular endothelial growth factor.
Jing Y; Ma N; Fan T; Wang C; Bu X; Jiang G; Li R; Gao L; Li D; Wu M; Wei L
Cancer Invest; 2011 Aug; 29(7):485-93. PubMed ID: 21740086
[TBL] [Abstract][Full Text] [Related]
17. Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo.
Terraneo L; Bianciardi P; Caretti A; Ronchi R; Samaja M
Prostate; 2010 Aug; 70(11):1243-54. PubMed ID: 20333700
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
19. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
20. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
